Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Kimia Farma Persero Tbk's Enterprise Value is Rp10,089,983 Mil.
PT Kimia Farma Persero Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was Rp136,966 Mil. Therefore, PT Kimia Farma Persero Tbk's EV-to-FCF for today is 73.67.
The historical rank and industry rank for PT Kimia Farma Persero Tbk's EV-to-FCF or its related term are showing as below:
ISX:KAEF'
s EV-to-FCF Range Over the Past 10 Years
Min: -445.34 Med: -18.02 Max: 205.23
Current: 73.91
During the past 13 years, the highest EV-to-FCF of PT Kimia Farma Persero Tbk was 205.23. The lowest was -445.34. And the median was -18.02.
ISX:KAEF's EV-to-FCF is ranked worse than 86.76% of 68
companies
in the Medical Distribution industry
Industry Median: 17.655
vs ISX:KAEF: 73.91
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Kimia Farma Persero Tbk (ISX:KAEF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Kimia Farma Persero Tbk's PE Ratio (TTM) for today is calculated as:
PT Kimia Farma Persero Tbk's share price for today is Rp436.00.
PT Kimia Farma Persero Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-41.250.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Kimia Farma Persero Tbk EV-to-FCF Related Terms
PT Kimia Farma Persero Tbk EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Kimia Farma Persero Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Persero Tbk EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Persero Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Persero Tbk's EV-to-FCF falls into.
PT Kimia Farma Persero Tbk's current Enterprise Value is Rp10,089,983 Mil.
PT Kimia Farma Persero Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp136,966 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Persero Tbk (ISX:KAEF) has a EV-to-FCF of 73.67 as of Aug. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Kimia Farma Persero Tbk and its competitors. According to the industry distribution chart, PT Kimia Farma Persero Tbk ranks #59 out of 68 companies in the Medical Distribution industry, placing it in the top 86.8%.
Is PT Kimia Farma Persero Tbk's EV-to-FCF too high?
PT Kimia Farma Persero Tbk's current EV-to-FCF is 73.67. The Medical Distribution industry median EV-to-FCF is 17.66. PT Kimia Farma Persero Tbk's value of 73.67 is 317.3% above this industry median. Based on the distribution chart, PT Kimia Farma Persero Tbk ranks #59 out of 68 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Persero Tbk ranks #59 out of 68 companies for EV-to-FCF. This places PT Kimia Farma Persero Tbk in the lower half of its industry. The industry median EV-to-FCF is 17.66. PT Kimia Farma Persero Tbk's value of 73.67 is 317.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.66, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Kimia Farma Persero Tbk's current EV-to-FCF of 73.67 is 317.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Kimia Farma Persero Tbk and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Persero Tbk's current EV-to-FCF is 73.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp579.52, compared to a current price of Rp436.00 — trading 24.8% below its estimated fair value. The current EV-to-FCF is 73.67 and 317.3% above the Medical Distribution industry median of 17.66. PT Kimia Farma Persero Tbk's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current EV-to-FCF is 73.67 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued.
The current stock price of Rp436.00 is trading 24.8% below its estimated GF Value™ of Rp579.52.
GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
EV-to-FCF: 73.67
GF Value™: Rp579.52 vs. price of Rp436.00 (24.8% below fair value)
Industry Position: 317.3% above the Medical Distribution median (#59 of 68)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
57GF Score
Get the complete analysis for ISX:KAEF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
